Product logins

Find logins to all Clarivate products below.


ENT Devices | Market Insights | Europe (Supplemental) | 2023

Despite the impact of the ongoing COVID-19 pandemic, the market is expected to stabilize, following which overall ENT procedure volumes will grow only slightly in Europe through 2030, hampered by growing developments in alternative treatment such as antibiotics and continued effort of various associations to promote alternatives to surgery. However, ongoing adoption of premium-priced devices, innovative devices such as Eustachian tube balloon dilation devices, and a general trend toward flexible endoscopy will drive the minimal growth of this market through 2030.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in Europe across an 11-year period.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…